Embecta Corp. Income Statement
EMBC / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Embecta Corp. reported $1.1B in revenue and $95M in net income for FY2025. Revenue has declined at a 0.1% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B |
| Cost of Revenue | $403.6M | $387.9M | $370.9M | $354.6M | $364.9M | $322.9M |
| Gross Profit | $676.8M | $735.2M | $749.9M | $774.9M | $800.4M | $762.6M |
| SG&A Expense | $332.0M | $365.1M | $341.3M | $294.8M | $240.3M | $214.7M |
| R&D Expense | $37.3M | $78.8M | $85.2M | $66.9M | $63.3M | $61.4M |
| Operating Income | $242.1M | $166.8M | $221.5M | $309.6M | $492.0M | $486.5M |
| Income Tax | $40.9M | -$34.1M | $35.3M | $33.0M | $80.1M | $58.2M |
| Net Income | $95.4M | $78.3M | $70.4M | $223.6M | $414.8M | $427.6M |
| EPS (Basic) | $1.23 | $3.92 | $1.23 | $3.92 | $7.28 | $7.50 |
| EPS (Diluted) | $1.22 | $3.89 | $1.22 | $3.89 | $7.28 | $7.50 |
| Shares Outstanding | 57.7M | 57.3M | 57.3M | 57.1M | 57.0M | 57.0M |
| Gross Margin | 62.6% | 65.5% | 66.9% | 68.6% | 68.7% | 70.3% |
| Operating Margin | 22.4% | 14.8% | 19.8% | 27.4% | 42.2% | 44.8% |
| Profit Margin | 8.8% | 7.0% | 6.3% | 19.8% | 35.6% | 39.4% |